Richard has been involved in the development diagnostic and therapeutic pharmaceutical products for more than twenty years.
Cytox Limited - a UK-based company with a unique scientific and proprietary technology platform. Through the application of this fundamental science and our specific know-how, we are elucidating the biology and genetics behind dementia, as well as developing prognostics tests for cognitive decline and individual risk of developing AD or other dementias. Contact us to find out more about our plans and how you could work with us.
The business and science team is supported by an experienced Board of Directors:
Andrew Carr Chairman
Richard Pither CEO
Zsuzsanna Nagy CSO
The North West Fund for Biomedical Non-executive Directors
The Board of Directors
Dr Nagy is well known for her ground-breaking work on the involvement of the cell cycle in neurodegenerative diseases which started a new chapter in the history of neurodegeneration research.
Andrew has already worked with Cytox in an advisory capacity and brings a wealth of highly relevant experience from both large companies and smaller biotechs